Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35,091 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy And Safety Of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Formulated Using Co-Suspension Delivery Technology In Chinese Patients With COPD.
Chen R, Zhong N, Wang HY, Zhao L, Mei X, Qin Z, Huang J, Assam PN, Maes A, Siddiqui S, Martin UJ, Reisner C. Chen R, et al. Among authors: zhao l. Int J Chron Obstruct Pulmon Dis. 2020 Jan 8;15:43-56. doi: 10.2147/COPD.S223638. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32021143 Free PMC article. Clinical Trial.
The Efficacy and Safety of Once-daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-daily Budesonide/Formoterol in a Subgroup of Patients from China with Symptomatic COPD at Risk of Exacerbations (FULFIL Trial).
Zheng J, Zhong N, Wang C, Huang Y, Chen P, Wang L, Hui F, Zhao L, Wang H, Luo L, Du X, Han Goh A, Lipson DA. Zheng J, et al. Among authors: zhao l. COPD. 2018 Jun-Aug;15(4):334-340. doi: 10.1080/15412555.2018.1481022. Epub 2018 Sep 28. COPD. 2018. PMID: 30265816 Clinical Trial.
Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial.
Zheng J, Baldi S, Zhao L, Li H, Lee KH, Singh D, Papi A, Grapin F, Guasconi A, Georges G. Zheng J, et al. Among authors: zhao l. Respir Res. 2021 Mar 23;22(1):90. doi: 10.1186/s12931-021-01683-2. Respir Res. 2021. PMID: 33757520 Free PMC article. Clinical Trial.
A randomized, double-blind, multicenter Phase II study comparing the efficacy and safety of oral nemonoxacin with oral levofloxacin in the treatment of community-acquired pneumonia.
Liu Y, Zhang Y, Wu J, Zhu D, Sun S, Zhao L, Wang X, Liu H, Ren Z, Wang C, Xiu Q, Xiao Z, Cao Z, Cui S, Yang H, Liang Y, Chen P, Lv Y, Hu C, Lv X, Liu S, Kuang J, Li J, Wang D, Chang L. Liu Y, et al. Among authors: zhao l. J Microbiol Immunol Infect. 2017 Dec;50(6):811-820. doi: 10.1016/j.jmii.2015.09.005. Epub 2015 Dec 1. J Microbiol Immunol Infect. 2017. PMID: 26748734 Free article. Clinical Trial.
The effects of CXCL10 polymorphisms on COPD susceptibility.
Wang Y, Zhou Q, Dong L, Xiong M, Jiang H, Guo M, Zhao L, Yuan L, Li Z, Liu H, Wang J, Zhong N, Lu W. Wang Y, et al. Among authors: zhao l. Mol Genet Genomics. 2018 Jun;293(3):649-655. doi: 10.1007/s00438-017-1408-z. Epub 2017 Dec 28. Mol Genet Genomics. 2018. PMID: 29285564
Long-Term Ozone Exposure and Small Airway Dysfunction: The China Pulmonary Health (CPH) Study.
Niu Y, Yang T, Gu X, Chen R, Meng X, Xu J, Yang L, Zhao J, Zhang X, Bai C, Kang J, Ran P, Shen H, Wen F, Huang K, Chen Y, Sun T, Shan G, Lin Y, Wu S, Zhu J, Wang R, Shi Z, Xu Y, Ye X, Song Y, Wang Q, Zhou Y, Ding L, Yang T, Yao W, Guo Y, Xiao F, Lu Y, Peng X, Zhang B, Xiao D, Wang Z, Zhang H, Bu X, Zhang X, An L, Zhang S, Cao Z, Zhan Q, Yang Y, Liang L, Cao B, Dai H, Wu T, He J, Li H, Kan H, Wang C; China Pulmonary Health Study Group. Niu Y, et al. Among authors: zhao j. Am J Respir Crit Care Med. 2022 Feb 15;205(4):450-458. doi: 10.1164/rccm.202107-1599OC. Am J Respir Crit Care Med. 2022. PMID: 34813411
35,091 results
You have reached the last available page of results. Please see the User Guide for more information.